Favorable Activity of CD19-Targeted Chimeric Antigen Receptor (CD19CAR) T Cell Therapy in Adults with Relapsed/ Refractory (R/R) ALL Including Extramedullary Disease (EMD) and Ph-like Genotype, Using Naive/Memory (Tn/ Mem) Derived T Cells

Saved in:
Bibliographic Details
Published inTransplantation and cellular therapy Vol. 28; no. 3; p. S201
Main Authors Aldoss, Ibrahim, Khaled, Samer K., Blanchard, M. Suzette, Wang, Xiuli, Wagner, Jamie R., Clark, Mary, Simpson, Jennifer, Paul, Jinny, Stein, Anthony S., Pullarkat, Vinod, Salhotra, Amandeep, Al Malki, Monzr M., Thomas, Sandra, Budde, Lihua E., Marcucci, Guido, Brown, Christine E., Forman, Stephen J.
Format Journal Article
LanguageEnglish
Published 01.03.2022
Online AccessGet full text

Cover

More Information
ISSN:2666-6367
2666-6367
DOI:10.1016/S2666-6367(22)00407-9